NURL logo

Neural Therapeutics Inc. Stock Price

CNSX:NURL Community·CA$4.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NURL Share Price Performance

CA$0.025
-0.00 (-16.67%)
CA$0.025
-0.00 (-16.67%)
Price CA$0.025

NURL Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

Neural Therapeutics Inc. Key Details

CA$0

Revenue

CA$0

Cost of Revenue

CA$0

Gross Profit

CA$1.4m

Other Expenses

-CA$1.4m

Earnings

Last Reported Earnings
Apr 30, 2025
Next Reporting Earnings
n/a
-0.0083
0%
0%
-124.3%
View Full Analysis

About NURL

Founded
2020
Employees
n/a
CEO
Ian Campbell
WebsiteView website
www.neuraltherapeutics.ca

Neural Therapeutics Inc., a drug discovery company, focuses on plant-based active substances. It focuses on San Pedro, a cactus containing mescaline and delivers over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments. Neural Therapeutics Inc. was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Recent NURL News & Updates

Recent updates

No updates